Cyanosis surgery: Difference between revisions
Line 59: | Line 59: | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
❑ Symptomatic Moderate to severe [[pulmonary | ❑ Symptomatic Moderate to severe [[pulmonary regurgitation]] after repaired [[TOF]] in which symptoms can not be explained otherwise.<br> | ||
<span style="font-size:85%;color:red"> [[Definition|<span style="color:red">Definition:</span>]] The combination of Right ventricle hypertrophy, VSD, PS, Overridding aorta</span><br> | <span style="font-size:85%;color:red"> [[Definition|<span style="color:red">Definition:</span>]] The combination of Right ventricle hypertrophy, VSD, PS, Overridding aorta</span><br> | ||
|- | |- | ||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[ | |style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Pulmonary valve replacement ]] ( surgical or percutaneous in [[Tetralogy of fallot]] : ([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence B]])''' | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | ||
❑ Asymptomatic moderate to severe [[ pulmonary regurgitation]] after repaired [[TOF]]<br> | ❑ Asymptomatic moderate to severe [[ pulmonary regurgitation]] after repaired [[TOF]]<br> | ||
<span style="font-size:85%;color:red"> Pulmonary stenosis valvotomy:<span style="color:red"> Surgical or balloon valvotomy in case of severe PS during infancy or childhood is recommended. Both of interventions can result pulmonary regurgitation and right ventricle dilation in the future and the need for pulmonary valve replacement.</span><br> | <span style="font-size:85%;color:red"> Pulmonary stenosis valvotomy:<span style="color:red"> Surgical or balloon valvotomy in case of severe PS during infancy or childhood is recommended. Both of interventions can result pulmonary regurgitation and right ventricle dilation in the future and the need for pulmonary valve replacement.</span><br> | ||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Tricuspid valve replacement ]] in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class I, Level of Evidence B]])''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ Symptomatic severe [[tricuspid regurgitaion]] accompanied by preserved or mildly systolic dysfunction of systemic ventricle<br> | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for [[Tricuspid valve replacement ]] in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class 2a, Level of Evidence C]])''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ Asymptomatic severe [[tricuspid regurgitation]] accompanied by mildly dilated systemic [[ventricle]]<br> | |||
|- | |||
|style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |'''Indication for conduit intervention/replacement in [[CCTGA]] : ([[ACC AHA guidelines classification scheme|Class 2b, Level of Evidence B]])''' | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #F5F5F5; width: 70%" align=left| | |||
❑ Symptomatic subpulmonary [[left ventricle]] to [[pulmonary artery]] conduit dysfunction <br> | |||
|} | |} | ||
Revision as of 14:28, 27 October 2020
Cyanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cyanosis surgery On the Web |
American Roentgen Ray Society Images of Cyanosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Recommendation for surgery in cyanotic heart disease
Recommendation for surgery in cyanotic congenital heart disease |
Indications for repair of a scimitar vein in Anomalous pulmonary venous connection (TAPVC) (Class I, Level of Evidence B ): |
❑ Decreased functional capacity |
Indications for surgery in Anomalous Pulmonary Venous Connections (TAPVC)(Class 2a, Level of Evidence B) : |
❑ Asymptomatic adults with right ventricle volume overload |
Indications for surgery repair or reoperation in Ebstein anomaly : (Class I, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indications for surgery repair or reoperation in Ebstein anomaly:(Class 2a, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indication for Glenn anastomousis at the time of repair in Ebstein anomaly : (Class 2b, Level of Evidence B) |
❑ Severe right ventricle dilation |
Indication for pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot (Class I, Level of Evidence B): |
❑ Symptomatic Moderate to severe pulmonary regurgitation after repaired TOF in which symptoms can not be explained otherwise. |
Indication for Pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot : (Class 2a, Level of Evidence B) |
❑ Asymptomatic moderate to severe pulmonary regurgitation after repaired TOF |
Indication for Tricuspid valve replacement in CCTGA : (Class I, Level of Evidence B) |
❑ Symptomatic severe tricuspid regurgitaion accompanied by preserved or mildly systolic dysfunction of systemic ventricle |
Indication for Tricuspid valve replacement in CCTGA : (Class 2a, Level of Evidence C) |
❑ Asymptomatic severe tricuspid regurgitation accompanied by mildly dilated systemic ventricle |
Indication for conduit intervention/replacement in CCTGA : (Class 2b, Level of Evidence B) |
❑ Symptomatic subpulmonary left ventricle to pulmonary artery conduit dysfunction |